Apraxia Market Share

Apraxia Market Overview

The Apraxia Market Size was valued at USD 2.32 Billion in 2023. The Global Apraxia industry is projected to grow from USD 2.56 Billion in 2024 to USD 4.08 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.43% during the forecast period (2024 - 2032). 

Apraxia is a neurological condition. Also, it is known as a motor disorder caused by damage to the brain. In this case, patients who find it difficult or impossible to make certain motor movements, even though their muscles are normal. Apraxia can occur in different forms one of which is orofacial apraxia. In which, patients are unable to voluntarily perform certain movements involving facial muscles. For instance, they may not be able to wink. Another form of apraxia affects a patient’s ability to intentionally move arms and legs.

Whereas in children apraxia of speech (CAS) has a number of possible causes, but in many cases, the cause can't be determined and often don't observe a problem in the brain ischemia of a child with CAS. CAS may be the result of brain (neurological) conditions or injuries, such as a stroke, infections or traumatic brain injury.

The apraxia market growth is majorly attributed to the increasing prevalence of neurological disorders, increasing investment of biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drive the growth of the market. 

Moreover, favorable reimbursement policies, increased application and significant investments in the development of new technologies for the treatment of various neurological diseases are likely to fuel the Apraxia Market growth during the forecast period.

According to the WHO estimates, neurological disorders are responsible for 4.5%-11% of all illnesses including low or high-income economies. This is far higher as compared to the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden is expected to increase further over the coming years.

However, the high cost of this treatment procedure may hamper the Apraxia Market growth during the corresponding period.

The global apraxia market is expected to grow at a CAGR of ~ 6.90 % during the forecast period 2023-2030. 

Intended Audience

• Pharmaceutical Companies


• Research and Development (R&D) Companies


• Government Research Institute


• Academic Institutes and Universities


• Medical Research Laboratories


• Market Research and Consulting Service Providers


• Potential Investors 

Apraxia Market Segmentations

The apraxia market has been segmented on the basis of types, diagnosis, treatment, and end user.

On the basis of the types, the market is segmented into ideomotor apraxia, ideational/conceptual apraxia, buccofacial or orofacial apraxia, constructional apraxia, gait apraxia, limb-kinetic apraxia, oculomotor apraxia, apraxia of speech.

On the basis of the diagnosis, the market is segmented into a test to measure upper limb apraxia, MRI, and others.

On the basis of the treatment, the market is segmented into speech therapy, occupational therapy, physical therapy, and others.

On the basis of the ‘end user, the market is segmented into hospitals & clinics, research centers, and others. 

Apraxia Market Regional Analysis

The Americas dominate the global apraxia market owing to well-developed technology, increasing prevalence of neurological disorders, high health care spending, and increasing government support for research & development. Furthermore, increasing R&D activities and the presence of major companies have fuelled the growth of the market in this region.

Europe holds the second position in the apraxia market. The government support for research & development and availability of funds for research are projected to drive the market in Europe region over the review period.  

Asia Pacific is the fastest growing apraxia market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing new opportunities in countries like China, India, Japan, and South Korea will make this as emerging and the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare is likely to lead the use of advanced equipment, which, in turn, will increase the growth of the market in the region.

On the other hand, the Middle East & Africa holds the least share of the market due to limited availability of medical facilities, less availability of funds, and poor political conditions in Africa.

Key Players in the Apraxia Market

Some of key the players in the market are: 

• Medtronic Plc.


• Codman & Shurtleff, Inc.


• Raumedic AG


• Vittamed, Sophysa Ltd.


• MicroPort Scientific Corporation


• Orsan Medical Technologies


• Spiegelberg GmbH


• Johnson & Johnson


• Sophysa Ltd


• HaiWeiKang


• Head Sense Medical


• InfraScan, Inc.


• Integra Life Sciences Corporation